Naomi Richards

Statistics

Publications

Citations

250

H-Index

Active since

2002

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Age UK

Research Triangle Park Foundation

Naomi Richards is an author at GlaxoSmithKline (United Kingdom) specializing in antiretroviral therapy, molecular virology, and protease inhibitor resistance.

Publications per year

2002–2004

Publications

Changes in Human Immunodeficiency Virus Type 1 Gag at Positions L449 and P453 Are Linked to I50V Protease Mutants In Vivo and Cause Reduction of Sensitivity to Amprenavir and Improved Viral Fitness In Vitro

Michael Maguire, Rosario Guinea, Philip Griffin et al. · Journal of Virology · 2002 · 158 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

GW433908/ritonavir once daily in antiretroviral therapy-naive HIV-infected patients

S. MacManus, Phillip J. Yates, Robert C. Elston et al. · AIDS · 2004 · 67 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

HIV-1 Reverse Transcriptase and Protease Resistance Mutations Selected during 16–72 Weeks of Therapy in Isolates from Antiretroviral Therapy-Experienced Patients Receiving Abacavir/Efavirenz/Amprenavir in the CNA2007 Study

Mounir Ait‐Khaled, Abdelrahim Rakik, Philip Griffin et al. · Antiviral Therapy · 2003 · 25 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

1–3 of 3